Indicaton

Tisotumab vedotin (TV) is an investigational antibody-drug conjugate (ADC) designed to target the Tissue Factor antigen and is being developed in cervical cancer as well as other solid tumors.

Therapeutic indications
Type of product
Table
  • Phase

    Phase II started

  • Partnering status

    Partnered

  • Partner

    Genmab A/S